Azorín-Vega E - Search Results

1

Improving Overall Survival and Quality of Life in Patients with Prostate Cancer and Neuroendocrine Tumors Using ¹⁷⁷Lu-iPSMA and ¹⁷⁷Lu-DOTATOC: Experience after 905 Treatment Doses.

Luna-Gutiérrez M, Hernández-Ramírez R, Soto-Abundiz A, García-Pérez O, Ancira-Cortez A, López-Buenrostro S, Gibbens-Bandala B, Soldevilla-Gallardo I, Lara-Almazán N, Rojas-Pérez M, Ocampo-García B, Azorín-Vega E, Santos-Cuevas C, Ferro-Flores G. Luna-Gutiérrez M, et al. Among authors: azorin vega e. Pharmaceutics. 2023 Jul 20;15(7):1988. doi: 10.3390/pharmaceutics15071988. Pharmaceutics. 2023. PMID: 37514174 Free PMC article.

2

Evaluation of the cytotoxic and genotoxic potential of the captan-based fungicides, chlorothalonil-based fungicides and methyl thiophanate-based fungicides in human fibroblasts BJ.

Moo-Muñoz AJ, Azorín-Vega EP, Ramírez-Durán N, Moreno-Pérez PA. Moo-Muñoz AJ, et al. Among authors: azorin vega ep. J Environ Sci Health B. 2021;56(10):877-883. doi: 10.1080/03601234.2021.1972721. Epub 2021 Sep 6. J Environ Sci Health B. 2021. PMID: 34486949

3

Multifunctional radiolabeled nanoparticles for targeted therapy.

Ferro-Flores G, Ocampo-García BE, Santos-Cuevas CL, Morales-Avila E, Azorín-Vega E. Ferro-Flores G, et al. Curr Med Chem. 2014;21(1):124-38. doi: 10.2174/09298673113209990218. Curr Med Chem. 2014. PMID: 23992338 Review.

4

Multifunctional targeted therapy system based on (99m) Tc/(177) Lu-labeled gold nanoparticles-Tat(49-57)-Lys(3) -bombesin internalized in nuclei of prostate cancer cells.

Jiménez-Mancilla N, Ferro-Flores G, Santos-Cuevas C, Ocampo-García B, Luna-Gutiérrez M, Azorín-Vega E, Isaac-Olivé K, Camacho-López M, Torres-García E. Jiménez-Mancilla N, et al. J Labelled Comp Radiopharm. 2013 Nov;56(13):663-71. doi: 10.1002/jlcr.3087. Epub 2013 Jul 19. J Labelled Comp Radiopharm. 2013. PMID: 25196028

5

Tumoral fibrosis effect on the radiation absorbed dose of (177)Lu-Tyr(3)-octreotate and (177)Lu-Tyr(3)-octreotate conjugated to gold nanoparticles.

Azorín-Vega EP, Zambrano-Ramírez OD, Rojas-Calderón EL, Ocampo-García BE, Ferro-Flores G. Azorín-Vega EP, et al. Appl Radiat Isot. 2015 Jun;100:96-100. doi: 10.1016/j.apradiso.2014.09.005. Epub 2014 Sep 18. Appl Radiat Isot. 2015. PMID: 25305748

6

Theranostic Radiopharmaceuticals Based on Gold Nanoparticles Labeled with (177)Lu and Conjugated to Peptides.

Ferro-Flores G, Ocampo-García BE, Santos-Cuevas CL, de María Ramírez F, Azorín-Vega EP, Meléndez-Alafort L. Ferro-Flores G, et al. Curr Radiopharm. 2015;8(2):150-9. doi: 10.2174/1874471008666150313115423. Curr Radiopharm. 2015. PMID: 25771363

7

Two Novel Nanosized Radiolabeled Analogues of Somatostatin for Neuroendocrine Tumor Imaging.

Orocio-Rodríguez E, Ferro-Flores G, Santos-Cuevas CL, Ramírez Fde M, Ocampo-García BE, Azorín-Vega E, Sánchez-García FM. Orocio-Rodríguez E, et al. J Nanosci Nanotechnol. 2015 Jun;15(6):4159-69. doi: 10.1166/jnn.2015.9620. J Nanosci Nanotechnol. 2015. PMID: 26369025

8

Synthesis and evaluation of Lys¹(α,γ-Folate)Lys³(¹⁷⁷Lu-DOTA)-Bombesin(1-14) as a potential theranostic radiopharmaceutical for breast cancer.

Aranda-Lara L, Ferro-Flores G, Azorín-Vega E, Ramírez FM, Jiménez-Mancilla N, Ocampo-García B, Santos-Cuevas C, Isaac-Olivé K. Aranda-Lara L, et al. Appl Radiat Isot. 2016 Jan;107:214-219. doi: 10.1016/j.apradiso.2015.10.030. Epub 2015 Oct 28. Appl Radiat Isot. 2016. PMID: 26545016

9

Comparative Effect Between Laser and Radiofrequency Heating of RGD-Gold Nanospheres on MCF7 Cell Viability.

Sánchez-Hernández L, Ferro-Flores G, Jiménez-Mancilla NP, Luna-Gutiérrez MA, Santos-Cuevas CL, Ocampo-García BE, Azorín-Vega E, Isaac-Olivé K. Sánchez-Hernández L, et al. J Nanosci Nanotechnol. 2015 Dec;15(12):9840-8. doi: 10.1166/jnn.2015.10328. J Nanosci Nanotechnol. 2015. PMID: 26682422

10

Clinical translation of a PSMA inhibitor for ^99mTc-based SPECT.

Ferro-Flores G, Luna-Gutiérrez M, Ocampo-García B, Santos-Cuevas C, Azorín-Vega E, Jiménez-Mancilla N, Orocio-Rodríguez E, Davanzo J, García-Pérez FO. Ferro-Flores G, et al. Nucl Med Biol. 2017 May;48:36-44. doi: 10.1016/j.nucmedbio.2017.01.012. Epub 2017 Feb 3. Nucl Med Biol. 2017. PMID: 28193503

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page